[1]
Maestroni, U. et al. 2021. Oncologic outcome of salvage high-intensity focused ultrasound (HIFU) in radiorecurrent prostate cancer. A systematic review. Acta Biomedica Atenei Parmensis. 92, 4 (Sep. 2021), e2021191. DOI:https://doi.org/10.23750/abm.v92i3.11475.